There’s Something Awry at Sangamo Therapeutics Inc (NASDAQ:SGMO) Since Share Price Gets Ahead of Fundamentals
The stock of Sangamo Therapeutics Inc (NASDAQ:SGMO) last traded at $0.70, down -27.55% from the previous session. SGMO stock price is now -7.20% away from the 50-day moving average and -11.70% away from the 200-day moving average. The market capitalization of the company currently stands at $125.77M. With the price target reduced from $6 to […]
There is little time left for Sangamo Therapeutics Inc (SGMO) to reach its 1-year target estimate. How soon will it surpass it?
Sangamo Therapeutics Inc (NASDAQ:SGMO) shares traded -3.67% lower at $0.58 on Wall Street last session. In accordance with the data, 11 analysts cover Sangamo Therapeutics Inc (NASDAQ:SGMO). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $10.00 and a low of $1.50, […]
Do investors have a safe investment in Sangamo Therapeutics Inc. (NASDAQ:SGMO)?
The price of Sangamo Therapeutics Inc. (NASDAQ:SGMO) shares last traded on Wall Street fell -2.66% to $1.28. Based on available information, 11 analysts follow Sangamo Therapeutics Inc. (NASDAQ:SGMO). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $16.00 and a low of […]
Reasons why Sangamo Therapeutics Inc.’s (NASDAQ:SGMO) fundamentals are futile
In yesterday’s Wall Street session, Sangamo Therapeutics Inc. (NASDAQ:SGMO) shares traded at $1.44, up 0.70% from the previous session. 11 analysts cover Sangamo Therapeutics Inc. (NASDAQ:SGMO), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $16.00 and a […]